Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Hypoxic-ischemic encephalopathy
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
Analyst Coverage
22-Sep-2022
View Update Report: MST Access 27 September 2022
27-Jul-2022
View Update Report: MST Access 27 July 2022
18-Jul-2022
View Update Report: MST Access 18 July 2022
30-Mar-2022
View Update Report: MST Access 30 March 2022
14-Feb-2022
View Update Report: MST Access 14 February 2022
12-Nov-2021
View Update Report 12 November 2021
22-Sep-2021
View Extract - Edition 902 22 September 2021
8-Sep-2021
View Extract - Edition 901 8 September 2021
11-Aug-2021
View Update Report 11 August 2021
11-Aug-2021
View Extract - Edition 899 11 August 2021
15-Jun-2021
View Extract - Edition 895 15 June 2021
19-Apr-2021
View Extract - Edition 888 19 April 2021
18-Feb-2021
View Update Report 18 Feb 2021
16-Feb-2021
View Update Report 16 Feb 2021
5-Nov-2020
View Update Report 5 November 2020
28-May-2020
View Update Report 28 May 2020
14-Nov-2019
View Initiation Report 14 November 2019